The combination of tenofovir, didanosine, and lamivudine is not recommended when considering a new treatment regimen for therapy-naive or treatment-experienced patients with HIV infection.

Current safety data suggest that lamivudine, telbivudine, or tenofovir may be used during pregnancy. However, the timing in initiating antiviral therapy requires careful assessment of risks and ...

The optimal length of hepatitis B treatment is not clear, but long-term therapy appears safe and effective. Hepatitis B can develop resistance to older drugs such as lamivudine, but tenofovir and ...

(Gallant) (Arribas) The 48-week results of the HEAT study showed that Kivexa (abacavir/lamivudine) and Truvada (emtricitabine/TDF) resulted in similar rates of viral suppression when combined with ...